Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-03

Clinical Trial Update: Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease

View source ↗

Summary

A prospective observational study evaluating the effectiveness and health care resource use of ustekinumab (Stelara) in Crohn's disease, with results reported a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Crohn Disease | Status: COMPLETED